Validation of the siRNA and selection of the appropriate concentration were carried out using commercially-available cell lines that naturally express In1-ghrelin, such as MDA-MB-231 (breast cancer cell line) and LnCAP (prostate cancer cell line) (data not shown). The gene discussed is GHRL; the disease is prostate cancer.